Sookyong Koh
Neurology with Special Qualifications in Child Neurology · Chicago, ILNPI 1124096698
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $35,936 of the $59,512 with a category attached, or 60.4%. 30 manufacturers reported payments, led by Neurelis, Inc. at 27.1% of the total. 2025 is the largest year on record at $13,832, more than ten times the $548 reported in 2019.
Across 171 payments — averaging $348.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurelis, Inc.$16K
- Takeda Pharmaceuticals U.S.A., Inc.$12K
- SK Life Science, Inc.$7K
- UCB, Inc.$5K
- Jazz Pharmaceuticals Inc.$4K
- Livanova USA, Inc.$4K
- plus $11K from 24 others
Across 1 payment — averaging $1029.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Swedish Orphan Biovitrum AB$1K
What the payments were for
- Consulting fees$35,93660%
- Speaking & faculty fees$8,92515%
- Travel & lodging$5,3739%
- Food & beverage$8,68815%
- Education$4911%
- Gifts$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurelis, Inc. | 30 | $16,111 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $12,313 |
| SK Life Science, Inc. | 19 | $6,883 |
| UCB, Inc. | 26 | $5,012 |
| Jazz Pharmaceuticals Inc. | 14 | $4,269 |
| Livanova USA, Inc. | 19 | $3,550 |
| Zogenix Inc. | 6 | $2,550 |
| Biomarin Pharmaceutical Inc. | 7 | $2,538 |
| Zevra Therapeutics Inc | 1 | $2,200 |
| Aquestive Therapeutics, Inc. | 1 | $1,020 |
| DIXI Medical USA Corp | 2 | $981 |
| Neuropace, Inc. | 5 | $616 |
| Greenwich Biosciences, Inc. | 7 | $308 |
| E.r. Squibb & Sons, L.L.C. | 2 | $248 |
| Eisai Inc. | 2 | $144 |
| Genentech USA, Inc. | 1 | $119 |
| Immedica Pharma US, Inc. | 1 | $117 |
| Monteris Medical Corporation | 1 | $111 |
| J2 Bio-pharma LLC | 1 | $100 |
| Intrabio Inc | 1 | $52 |
| Biocodex, Inc. | 1 | $48 |
| Biogen | 2 | $43 |
| Azurity Pharmaceuticals, Inc. | 2 | $33 |
| Upsher-smith Laboratories LLC | 1 | $27 |
| Sunovion Pharmaceuticals Inc. | 1 | $25 |
| PTC Therapeutics, Inc. | 1 | $22 |
| Sobi, Inc | 1 | $21 |
| AbbVie | 1 | $20 |
| AstraZeneca | 1 | $16 |
| Acadia Pharmaceuticals Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VALTOCO$15,592
- Fintepla$6,775
- XCOPRI$5,828
- VNS Therapy$3,203
- Olpruva$2,200
- Brineura$2,143
- JZP-385$808
- JZP-150$808
- Epidiolex$766
- RNS Neurostimulator Kit$482
- ZEPOSIA$248
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$230
- Palynziq$145
- Nayzilam$121
- Fycompa$120
- EVRYSDI$119
- ZTALMY$117
- Neuroblate$111
How this compares
$59,512 in reported general payments places this provider in the 85th percentile of 57 neurology with special qualifications in child neurology providers in Illinois.
See all neurology with special qualifications in child neurology providers in Illinois →
Other neurology with special qualifications in child neurology in Chicago
- Douglas NordliChicago$621K
- Nancy KuntzChicago$503K
- Vamshi RaoChicago$124K
- John MillichapChicago$84K
- Elizabeth Berry-KravisChicago$38K
- Colleen BuhrfiendChicago$15K
- Bridget McGowanChicago$11K
- Peter HeydemannChicago$11K
- Divya DesaiChicago$3K
- Joseph CollinsChicago$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.